** Shares of Australia's Proteomics International Laboratories PIQ.AX rise as much as 7.6% to A$0.570, their highest level since late-February
** Medical technology firm secures U.S. patent for PromarkerEso diagnostic testfor early diagnosis of esophageal cancer
** Stock is down 28.8% YTD, including the session's moves
(Reporting by Anjali Singh in Bengaluru)
((anjali.singh2@thomsonreuters.com; ))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.